bimagrumab and semaglutide as a GLP-1 Agonist: A Breakthrough in Obesity Treatment Bimagrumab: a potential anti-obesity drug
Pay in 4 interest-free payments of $6.40 Learn more
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours · Estimated delivery Aug 23 - Aug 28

























